Pulse
AI care for cardiometabolic health
Proactive, always-on care across the full cardiometabolic spectrum, built to drive measurable outcomes in your highest-cost population.
the challenge
The system waits until it’s too late
Chronic disease requires daily management.
But care happens in brief, occasional visits.
Between appointments, risk escalates and costs rise.
120M Americans have hypertension
Only 1 in 5 has it controlled1
$400B+ spent annually on cardiovascular disease2
the model
One program for your most costly conditions
Hypertension, diabetes, weight, cholesterol, and GLP-1 support are driven by the same daily behaviors. Pulse targets those behaviors directly.
Structured movement programs designed for real life and sustained over time.
Improve blood pressure and metabolic health
Preserve lean muscle and mobility
Build sustainable activity habits
Personalized nutrition aligned to each member’s condition, medications,
Support glucose control and weight management
Improve cholesterol and blood pressure
Provide real-world guidance members can follow
Lifestyle change first, medication when necessary, guided by clinicians.
Reinforce adherence and daily consistency
Monitor progress and response to treatment
Inform smarter prescribing decisions
Evidence-based support for stress, sleep, and long-term habit change.
Reduce physiological strain on the cardiovascular system
Improve sleep and recovery
Strengthen long-term health behaviors
How Pulse delivers continuous care
Pulse replaces episodic care with a continuous clinical model designed to support daily behavior change, detect risk earlier, and drive measurable improvement.
Always-on care delivery
24/7 care for every member
Pulse reaches out to members proactively, responding in seconds before small lapses become costly claims. Members are always supported, reducing the barriers that cause disengagement.
Adaptive clinical model
Clinical precision that improves outcomes
Every member is matched to the right health specialist, who directs their journey, monitors progress and steps in when necessary.
Connected intelligence
Care grounded in real-world data
Connected devices capture blood pressure, weight, activity, and glucose in real time, giving Pulse the signals it needs to personalize support and intervene at the right moment.
Unified AI Care
One connected care conversation
One continuous conversation between the member, an AI care specialist, and a dedicated health specialist. Every interaction connected, every decision informed by the full picture.
Proactive Engagement
Retains clinical memory, personalizes support,
and engages proactively.
Clinical Oversight
Reviews member data, adapts care plans, and
applies human judgment when it matters most.
outcome-based pricing
Reduce risk with pricing directly tied to each member's results
We only get paid when your members achieve measurable outcomes.
50
%
is due after the Onboarding Call or First Session.
50
%
is only due when a positive, measurable member outcome is achieved.
What drives Pulse's financial impact?
See the clinical and economic evidence behind Pulse's outcomes-based pricing model.
2.5:1
gross ROI3
91%
member health improvements4
69%
members become active5
platform
The AI Care model
built around people
Human clinicians and AI work together to deliver continuous, personalized care that adapts as needs change, across conditions, moments, and stages of life.
Bring Pulse to your population
See how Pulse delivers measurable cardiometabolic outcomes for your population, with pricing tied to results.
Footnotes
Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension Prevalence, Awareness, Treatment, and Control Among Adults Aged 18 and Over: United States, August 2021–August 2023. NCHS Data Brief No. 511. Hyattsville, MD: National Center for Health Statistics; October 2024.
Martin SS, Aday AW, Almarzooq ZI, et al. 2025 Heart Disease and Stroke Statistics: A Report From the American Heart Association. Circulation. 2025;151(8):e535–e789.
Based on a health economic analysis of 1.57M lives with commercial claims data
Based on Move data. Percent of members who scored 5 or above on the PGIC scale from all those who answered a reassessment, +9 DWA
Based on Move data Over 500 MET-minutes per week, self-reported sitting time at the latest reassessment on or after 5 weeks into the program
Based on Move data. Percent of members who scored 5 or above on the PGIC scale from all those who answered a reassessment, +9 DWA
Conte C et al. Is Weight Loss-Induced Muscle Mass Loss Clinically Relevant? JAMA. 2024 Jul 2;332(1):9-10. doi: 10.1001/jama.2024.6586
